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Structural basis for the endoribonuclease activity
of the type III-A CRISPR-associated protein Csm6
OLE NIEWOEHNER and MARTIN JINEK
Department of Biochemistry, University of Zurich, Zurich CH-8057, Switzerland
ABSTRACT
Prokaryotic CRISPR–Cas systems provide an RNA-guided mechanism for genome defense against mobile genetic elements such as
viruses and plasmids. In type III-A CRISPR–Cas systems, the RNA-guided multisubunit Csm effector complex targets both single-
stranded RNAs and double-stranded DNAs. In addition to the Csm complex, efficient anti-plasmid immunity mediated by type III-
A systems also requires the CRISPR-associated protein Csm6. Here we report the crystal structure of Csm6 from Thermus
thermophilus and show that the protein is a ssRNA-specific endoribonuclease. The structure reveals a dimeric architecture
generated by interactions involving the N-terminal CARF and C-terminal HEPN domains. HEPN domain dimerization leads to
the formation of a composite ribonuclease active site. Consistently, mutations of invariant active site residues impair catalytic
activity in vitro. We further show that the ribonuclease activity of Csm6 is conserved across orthologs, suggesting that it plays
an important functional role in CRISPR–Cas systems. The dimer interface of the CARF domains features a conserved
electropositive pocket that may function as a ligand-binding site for allosteric control of ribonuclease activity. Altogether, our
work suggests that Csm6 proteins provide an auxiliary RNA-targeting interference mechanism in type III-A CRISPR–Cas
systems that operates in conjunction with the RNA- and DNA-targeting endonuclease activities of the Csm effector complex.
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INTRODUCTION
In many bacteria and most archaea, CRISPR–Cas systems
(for clustered regularly interspaced short palindromic re-
peats—CRISPR-associated) provide adaptive and heritable
immunity againstmobile genetic elements such as viruses and
plasmids (Barrangou et al. 2007; Marraffini and Sontheimer
2008, 2010; Wiedenheft et al. 2012; Sorek et al. 2013; van der
Oost et al. 2014). These RNA-guided genome defense sys-
tems typically consist of an array of short repeats intercalated
with invader-derived spacer sequences, and an operon con-
taining several CRISPR-associated (cas) genes encoding the
molecular machinery involved in spacer acquisition, guide
RNA processing, and target interference. Transcription of
CRISPR spacer-repeat arrays and subsequent processing of
the precursor transcripts yields individual CRISPR RNAs
(crRNAs) (Brouns et al. 2008; Carte et al. 2008; Hale et al.
2008; Haurwitz et al. 2010). These crRNA guides in turn as-
sociate with Cas proteins in effector complexes in which they
mediate target detection by Watson–Crick base-pairing in-
teractions (Brouns et al. 2008; Hale et al. 2009; Jore et al.
2011). Five types of CRISPR–Cas systems (types I–V) have
been identified, each having distinct composition of the cas
gene operon and distinct mechanisms of crRNA biogenesis
and crRNA-guided interference (Makarova et al. 2011a,
2015).
In type I CRISPR–Cas systems, multiple Cas proteins as-
semble with a mature crRNA in a large multisubunit com-
plex, termed Cascade, that facilitates recognition of double-
stranded DNA (dsDNA) targets (Brouns et al. 2008). Upon
target binding, the Cascade complex recruits the type I-spe-
cific helicase/exonuclease Cas3 that degrades the target
DNA in a processive manner (Brouns et al. 2008; Beloglazova
et al. 2011; Sinkunas et al. 2011; Westra et al. 2012). In con-
trast, type II and type V systems target dsDNA by means of
single effector proteins Cas9 and Cpf1, respectively, that
function as RNA-guided DNA endonucleases (Deltcheva et
al. 2011; Zetsche et al. 2015). Cas9 associates with a dual-
RNA guide structure consisting of a crRNA and a trans-acti-
vating CRISPR RNA (tracrRNA) and cleaves dsDNAwithin a
target sequence complementary to a 20-nucleotide (nt) guide
segment in the crRNA (Deltcheva et al. 2011; Gasiunas et al.
2012; Jinek et al. 2012). Type III CRISPR–Cas systems are
defined by the signature protein Cas10 and, in analogy with
type I systems, rely on multisubunit crRNA–Cas protein
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complexes for target recognition (Marraffini and Sontheimer
2008; Hale et al. 2009; Makarova et al. 2011a). The two type
III CRISPR–Cas system subtypes, type III-A and III-B, have
different subunit compositions and are thought to have dif-
ferent target specificities. The type III-B effector complex
(Cmr complex), containing proteins Cmr1, Cmr2/Cas10,
and Cmr3–6, has been shown to bind and cleave single-
stranded RNA (ssRNA) targets in vitro and in vivo (Hale
et al. 2009, 2012; Zhang et al. 2012; Staals et al. 2013;
Zebec et al. 2014). Within the Cmr complex, the Cmr4 sub-
units mediate cleavage of ssRNAs complementary to the
spacer-derived part of the crRNA at discrete 6-nt intervals
in a 5′ ruler-dependent manner (Staals et al. 2013; Benda et
al. 2014; Hale et al. 2014; Ramia et al. 2014; Zhu and Ye
2015). Type III-A effector complexes (Csm complexes) are
composed of a crRNA and Cas proteins Csm1/Cas10 and
Csm2–5 (Marraffini and Sontheimer 2008). The type III-A
CRISPR–Cas system is believed to target DNA based on its
ability to interfere with plasmid transformation and conjuga-
tion in Staphylococcus epidermidis (Marraffini and Son-
theimer 2008; Hatoum-Aslan et al. 2013, 2014). DNA
targeting by the S. epidermidis CRISPR–Cas system requires
active transcription of the target DNA, thereby enabling con-
ditional tolerance of temperate phages (Goldberg et al. 2014;
Peng et al. 2015). Purified Csm complexes from Streptococcus
thermophilus and Thermus thermophilus cleave ssRNA in vitro
by a mechanism similar to that of the Cmr complex (Staals
et al. 2014; Tamulaitis et al. 2014). The S. epidermidis Csm
complex has recently been shown to harbor two independent
endonuclease activities (Samai et al. 2015). The complex is
capable of cleaving ssRNA targets complementary to the
crRNA; additionally, the complex cleaves double-stranded
target DNAs within the nontemplate strand in a transcrip-
tion-dependent manner. Whereas the RNA cleavage activity
of the Csm complex is mediated by the Csm3 subunits (ho-
mologous to Cmr4 subunits of the Cmr complex), DNA
cleavage requires an intact palm polymerase domain in the
Csm1/Cas10 subunit (Samai et al. 2015). These results collec-
tively suggest that type III-A systems target both RNA and
DNA, which is further underscored by experiments showing
that type III-A systems are capable of restricting both DNA
and RNA bacteriophages in vivo (Goldberg et al. 2014;
Tamulaitis et al. 2014; Samai et al. 2015).
csm6 genes are frequently associated with type III CRISPR–
Cas systems (Makarova et al. 2011b). The Csm6 protein is
distantly related to the type I-A associated protein Csa3,
which has been suggested to function as a transcription factor
that controls Cas protein expression (Lintner et al. 2011). In
contrast to Csa3, in vivo experiments performed in S. epider-
midis have shown that Csm6 is not required for Csm complex
expression or assembly, suggesting that Csm6 does not func-
tion as a transcriptional regulator (Hatoum-Aslan et al.
2014). Instead, Csm6 is essential for crRNA-guided anti-plas-
mid interference, although it is not an integral component of
the Csm effector complex (Hatoum-Aslan et al. 2013, 2014).
Both Csm6 and its homologous protein Csx1 are members
of the COG1517 superfamily and are found in four distinct
Cas protein families (Anantharaman et al. 2013). Csx1 has
been shown to be required for the interference activity of a
type III-B CRISPR–Cas system in Sulfolobus islandicus
(Deng et al. 2013). Both Csm6 and Csx1 proteins share an
overall architecture defined by an N-terminal CARF domain
(CRISPR-associated Rossman fold) and a C-terminal HEPN
domain (higher eukaryotes and prokaryotes nucleotide-
binding domain) that contains a conserved R-X4-6-H motif
(Anantharaman et al. 2013; Kim et al. 2013). Domains be-
longing to the HEPN superfamily often exhibit ribonuclease
activity and are commonly found in prokaryotic toxin–anti-
toxin (T–A) and abortive infection (Abi) defense systems, as
well as in KEN (kinase-extension nuclease) domain-contain-
ing eukaryotic ribonucleases such as RNase L and Ire1
(Anantharaman et al. 2013). Due to the high conservation
of the putative HEPN domain active site in Csm6 proteins,
it is conceivable that these proteins function as ribonucleases.
In this study, we sought to shed light on the biochemical
function of Csm6 proteins in type III-A CRISPR–Cas sys-
tems. We report the crystal structure of T. thermophilus
Csm6 (TtCsm6) at 2.3 Å resolution and show that the protein
is a ssRNA-specific endoribonuclease. The HEPN domains in
the TtCsm6 dimer form a composite ribonuclease active site
whose architecture and function is likely conserved in other
Csm6 proteins. These results suggest that besides the intrinsic
RNA cleavage activity of the Csm effector complex mediated
by its Csm3 subunits, type III-A CRISPR–Cas systems harbor
an additional ribonuclease module—Csm6—whose activity
may play an important role in the interference mechanism.
RESULTS AND DISCUSSION
TtCsm is an ssRNA-specific endoribonuclease
The HEPN protein superfamily has recently been expanded
by the inclusion of four distinct Cas protein families, two
of which are classified as Csm6 proteins and two as Csx1 pro-
teins (Anantharaman et al. 2013). HEPN domains occur
across all domains of life and are characterized by the pres-
ence of a conserved motif conforming to the consensus
sequence R-X4-6-H (Anantharaman et al. 2013). The do-
mains are frequently found in ribonucleases and in several
of these the R-X4-6-H motif has been shown to be required
for catalytic activity (Davidov and Kaufmann 2008; Lee
et al. 2008; Han et al. 2014; Huang et al. 2014). The nuclease
activity of Csm6 proteins has not been tested to date, al-
though Pyrococcus furiosus Csx1 was previously shown to
be a nucleic acid-binding protein (Kim et al. 2013). We ex-
amined the HEPN domains in Csm6 and Csx1 proteins by
performing a multiple sequence alignment of representative
orthologs from organisms that have been investigated ex-
tensively in the CRISPR–Cas field (Fig. 1A). The overall
sequence identity in pairwise alignments was rather low,
Crystal structure of Csm6
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FIGURE 1. Thermus thermophilus Csm6 (TtCsm6) is a single-strand-specific endoribonuclease. (A) Multiple sequence alignment of Csm6 and Csx1
proteins from T. thermophilus (TtCsm6, GI:55978335), S. epidermidis (SeCsm6, GI:488416649), S. mutans (SmCsm6, GI:24379650), S. thermophilus
(StCsm6, GI:585230687), and P. furiosus Csx1 (PfCsx1, GI:33359545), performed using ClustalOmega (McWilliam et al. 2013). HEPN domain active
site residues aremarked with asterisks. Secondary structure elements of TtCsm6 are indicated above the sequences. Disordered amino acid residues are
indicated with dashed lines. (B) Nuclease activity assays performed with single- (ss) and double-stranded (ds) RNA and DNA oligonucleotide sub-
strates. The 24-nt substrates have identical sequences and carry a Cy5 fluorophore group covalently attached to the 3′-terminus. Double-stranded
substrates were prepared by annealing an unlabeled complementary strand to the respective single-stranded substrate. TtCsm6 (400 nM final con-
centration) was incubated with substrates (200 nM) at 37°C for 1 h. Cleavage products were analyzed by electrophoresis on a 15% denaturing poly-
acrylamide gel and detected using a fluorescence gel scanner. (C) Nuclease activity assays performed using TtCsm6 and identical ssRNA
oligonucleotide substrates (24 nt) labeled with Cy5 at the 5′ or 3′ ends. The assay was performed as in B. A control digest with RNase T1 was
used to generate RNA fragments of defined size, as indicated.
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ranging from∼9% to∼28%. However, the HEPN domain R-
X4-6-H motif was strictly conserved in all examined sequenc-
es, pointing to its conserved functional role in Csm6 and
Csx1 proteins, and therefore hinting that these proteins func-
tion as ribonucleases. To test this hypothesis, we expressed
and purified recombinant T. thermophilus Csm6 protein
(TtCsm6) and probed its nuclease activity using fluorescently
labeled RNA andDNA oligonucleotides. A randomly selected
RNA oligonucleotide sequence was efficiently cleaved by
TtCsm6 at 37°C to yield discrete shorter oligonucleotide
products (Fig. 1B). In contrast, a dsRNA duplex containing
the same oligonucleotide sequence was largely refractory to
cleavage; the trace amount of product generated by TtCsm6
was possibly due to duplex strand dissociation during
the cleavage reaction. Neither ssDNA nor dsDNA oligonu-
cleotides of the same nucleotide sequence were cleaved
by TtCsm6, indicating that the protein is a ribonuclease.
Furthermore, ssRNA cleavage by TtCsm6 was not perturbed
by the addition of EDTA, indicating that the activity of
TtCsm6 does not require divalent metals. To characterize
the cleavage activity of TtCsm6 further, we performed a nu-
clease activity assay using ssRNA oligonucleotide substrates
that were fluorescently labeled at either the 3′- or 5′-end. In
both cases, incubation of the substrate with TtCsm6 resulted
in the formation of shorter oligonucleotide products (Fig.
1C). This suggests that TtCsm6 harbors an endoribonuclease,
rather than exonuclease activity because covalent modifica-
tion of neither the 3′ nor the 5′ terminus with the Cy5 fluo-
rophore inhibited RNA cleavage. To examine the sequence/
base specificity of TtCsm6, we analyzed its activity against
synthetic 12-mer homo-oligonucleotides (U12, A12, and
C12). Incubation of all three substrates with TtCsm6 resulted
in the formation of anomalously migrating short oligonucle-
otide products, including the terminal dinucleotides (Sup-
plemental Fig. 1; Killelea et al. 2014). This suggests that the
enzymatic activity of TtCsm6 is largely sequence-unspecific
and does not appear to be selective for a specific substrate
or product length. Taken together, these experiments show
that TtCsm6 is a divalent metal-independent, ssRNA-specif-
ic, endoribonuclease. This is consistent with the catalytic ac-
tivities of other HEPN-domain ribonucleases such as Ire1,
RNase L, and the tRNA anticodon RNases PrrC and RloC,
which are all metal-independent enzymes (Davidov and
Kaufmann 2008; Lee et al. 2008; Meineke and Shuman
2012; Han et al. 2014; Huang et al. 2014).
To probe the chemistry of Csm6-catalyzed RNA hydroly-
sis, we digested the 3′-end labeled oligonucleotide with
TtCsm6 and subsequently incubated the cleavage products
with T4 polynucleotide kinase (PNK) in the presence of
ATP. Treatment with T4 PNK resulted in a marked shift in
electrophoretic mobility, indicating that the 3′ products of
Csm6-catalyzed phosphodiester bond hydrolysis carry a
free 5′-hydroxyl group (Supplemental Fig. 2). This suggests
that RNA substrate cleavage by Csm6 yields products con-
taining a 5′-hydroxyl and a 2′–3′ cyclic phosphate groups,
as shown for other HEPN domain RNases (Amitsur et al.
1987; Gonzalez et al. 1999; Davidov and Kaufmann 2008).
The crystal structure of TtCsm6 reveals
a dimeric architecture
To shed light on the molecular architecture of Csm6 and the
functional organization of its constituent domains, we deter-
mined the three-dimensional structure of TtCsm6 by X-ray
crystallography. TtCsm6 crystallization was dependent on
the presence of Ni2+ ions, which allowed us to solve the struc-
ture using single-wavelength anomalous diffraction (SAD)
phasing. The atomic model was refined at a resolution of
2.30 Å with Rwork of 21.9% and Rfree of 24.9% (Table 1).
The protein crystallized as a homodimer, consistent with
size-exclusion chromatography data indicating that the pro-
tein is dimeric in solution (Supplemental Fig. 3).
The TtCsm6 homodimer resembles an elongated X-shape
with overall dimensions of ∼120 Å × 70 Å × 60 Å. The poly-
peptide chains of the two protomers are arranged in a paral-
lel, head-to-head fashion, twisting around each other in a
right-handed double helix (Fig. 2A). The N-terminal region
of TtCsm6 (residues 1–184) comprises a CRISPR-associated
Rossman fold (CARF) domain and consists of five parallel
and two anti-parallel β-strands flanked by pairs of α-helices
on either side of the central β-sheet. The remainder of the
polypeptide, connected to the CARF domain via a short link-
er, is almost completely α-helical and is composed of two do-
mains. The middle region of the TtCsm6 polypeptide chain
(residues 191–292) consists of five α-helices and forms a
right-handed solenoid domain previously denoted as the
6H domain (Makarova et al. 2014). The C-terminal region
of TtCsm6 (residues 293–450) comprises eight α-helices
that form the HEPN domain. The C-terminus of the Csm6
polypeptide chain (residues 451–464) folds back onto the
6H domain of the same protomer.
The overall domain architecture of TtCsm6 is similar to
other members of the COG1517 superfamily whose struc-
tures have been determined. Csx1 proteins from P. furiosus
(PfCsx1, PDB ID: 4EOG) and Sulfolobus solfataricus
(SsCsx1, PDF ID: 2I71) contain both the N-terminal CARF
and the C-terminal HEPN domains but lack the middle 6H
region. Structural alignment performed using the DALI
server (Holm and Rosenström 2010) revealed that the N-ter-
minal CARF domain of TtCsm6 superimposes with the
CARF domains of PfCsx1 and SsCsx1 with a root mean
square deviation (rmsd) of 2.7 Å (over 124 Cα atoms) and
3.1 Å (over 127 Cα atoms), respectively (Fig. 2B). In contrast,
the C-terminal HEPN domains of TtCsm6, PfCsx1, and
SsCsx1 could not be superimposed. This is largely due to a
structural rearrangement of the HEPN domain in Csx1 pro-
teins due to the insertion of a β-hairpin, as noted previously
(Anantharaman et al. 2013). Streptococcus mutans Csm6
(SmCsm6, PDB ID: 4RGP) superimposes with an rmsd of
4.0 Å over 198 Cα atoms. In this case, the structural
Crystal structure of Csm6
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homology is restricted to the C-terminal HEPN domain
because SmCsm6 lacks the N-terminal CARF domain (Figs.
1A, 2B). The CARF domain of TtCsm6 also displays strong
structural homology with the putative transcriptional regula-
tor Csa3 from S. solfataricus, superimposing with an rmsd of
2.8 Å over 120 Cα atoms (Fig. 2B).
Dimerization of TtCsm6 buries∼2800 Å2 of solvent-acces-
sible surface area per chain and is mediated by two dimer in-
terfaces, one involving the N-terminal CARF domains and
the other comprising both the 6H and HEPN domains.
The CARF domain dimerization interface is centered on helix
α7 and involves largely hydrophobic contacts (Supplemental
Fig. 4). The 6H and HEPN domains dimerize via hydropho-
bic interactions involving amino acid residues provided by
helices α12 and α14 and by the loop connecting helices α18
and α19, which contains the R-X4-6-H motif (Supplemental
Fig. 4). Overall, the architecture of the
TtCsm6 dimer is similar to the crystallo-
graphic dimers of PfCsx1 and SsCsx1
(Kim et al. 2013). However, the hydro-
phobic nature of the dimerization inter-
face is the likely reason for TtCsm6
forming a stable homodimer in solution,
in contrast to PfCsx1 and SsCsx1, which
are both monomeric in solution. In this
respect, TtCsm6 resembles Csa3, which
also forms a stable homodimer (Lintner
et al. 2011).
The TtCsm6 dimer features
two putative nucleotide-binding
sites
Examination of the electrostatic surface
potential of TtCsm6 revealed the pres-
ence of two large positively charged
patches located at opposite ends of the
dimer, both centred on the dyad axis of
the dimer (Fig. 2C). The patches are
found in clefts formed by the respective
dimerization of the CARF and HEPN
domains. To analyze the phylogenetic
conservation of these clefts, we identified
the 50 closest nonredundant orthologs
of TtCsm6 using PSI-BLAST (Altschul
et al. 1997) and aligned their sequences
using COBALT (Supplemental Data
File 1; Papadopoulos and Agarwala
2007). Mapping amino acid sequence
conservation onto the molecular surface
of TtCsm6 using theConsurf server (Lan-
dau et al. 2005) shows that in contrast
to other regions of the Csm6 dimer,
both clefts are highly conserved, hinting
at their functional importance (Sup-
plemental Fig. 5). The CARF domain is a variant of the
Rossman fold, which is often found in nucleotide-binding en-
zymes (Hanukoglu 2015). CARF domains lack the canonical
G-X-G-X-(G/A)motif, suggesting that they do not bindNAD
(P)H or FADH2. Instead, they harbor a conserved (D/N)-X-
(S/T)-X3-(R/K)motif thatmaps to the canonical ligand-bind-
ing face of the Rossmann fold (Makarova et al. 2014). In
TtCsm6, this motif (Asp131–Lys137) is partially exposed
and forms the base of the deep cavity spanning the CARF
dimer interface (Supplemental Fig. 5). Although this motif
contributes to dimer formation, its surface accessibility points
to an additional function in ligand binding. It has previously
been proposed that CARF domain proteins such as Csa3
might recognize and be allosterically regulated by nucleotides
or nucleotide-derived metabolites (Lintner et al. 2011). The
evolutionary conservation of the CARF domain cleft in
Table 1. Crystallographic data collection and refinement statistics
Data set Native Ni SAD
X-ray source SLS X06DA (PXIII) SLS X06DA (PXIII)
Space group P21212 P21212
Cell dimensions
a, b, c (Å) 95.3, 207.1, 58.9 95.1,206.8, 58.9
α, β, γ (o) 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Wavelength (Å) 1.00000 1.48502
Resolution (Å)a 48.70–2.30 (2.44–2.30) 48.66–2.99 (3.07–2.99)
Rsym (%)
a 6.2 (94.9) 12.7 (84.2)
CC1/2a 0.999 (0.667) 1.000 (0.911)
I/σIa 17.9 (1.5) 28.6 (4.4)
Observationsa 663,646 (78,246) 1,282,053 (83,905)
Unique reflectionsa 98,111 (14,274) 45,402 (3310)
Multiplicitya 6.8 (5.5) 28.2 (25.3)
Completeness (%)a 98.0 (87.8) 99.9 (99.1)
Refinement
Resolution (Å) 48.70–2.30
No. reflections 98,030
Rwork/Rfree 0.219/0.244
No. atoms
Protein 6982
Ligands 6
Water 72
B-factors
Mean 78.1
Protein 78.2
Ligands 91.6
Water 60.5
R.m.s. deviations
Bond lengths (Å) 0.006
Bond angles (o) 0.78
Ramachandran plot
% Favored 96.7
% Allowed 3.3
% Outliers 0.0
aValues in parentheses denote highest resolution shell.
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TtCsm6 and its strong electropositive surface potential collec-
tively suggest that this might also be the case for Csm6 and
Csx1 proteins. The concave surface of the HEPN domain
dimer has previously been implicated in nucleic acid binding
in other Csm6/Csx1 proteins. PfCsx1 binds both dsDNA and
dsRNA using arginine side chains projecting into the HEPN
domain cleft (Kim et al. 2013). In TtCsm6, the cleft is 30 Å
long, 15 Å deep, and 13 Å wide at its narrowest point. Its
base is formed by the interlocking of the α18–α19 loops pro-
vided by the two HEPN domain protomers. These loops con-
tain the conserved R-X4-6-H motif, which has been shown to
mediate ribonuclease activity in other HEPN domain pro-
teins. Consistent with the observed ssRNA-selective ribonu-
clease activity of TtCsm6, the width of the cleft would
permit binding of a single-stranded nucleic acid substrate,
while sterically excluding double-stranded nucleic acids.
Taken together, the structural features of TtCsm6 dimer
thus suggest that the protein contains two ligand-binding
sites: a putative allosteric ligand-binding site at the interface
of the CARF domains, and an ssRNA-binding cleft located
at the HEPN domain interface, which harbors the ribonucle-
ase active center.
The HEPN domain dimer forms a composite
ribonuclease active site
Site-directed mutagenesis studies have shown that the con-
served R-X4-6-H motif is responsible for the catalytic activity
in a number of dimeric HEPN domain-containing ribonu-
cleases, including tRNA anticodon nucleases PrrC and
RloC, as well as the eukaryotic pseudokinase–ribonuclease
enzymes Ire1 and RNase L (Davidov and Kaufmann 2008;
Lee et al. 2008; Meineke and Shuman 2012; Han et al.
2014; Huang et al. 2014). The molecular architecture of
the TtCsm6 HEPN domain dimer is highly similar to that
of the kinase-ribonuclease Ire1 (Supplemental Fig. 6A,B).
In the TtCsm6 structure, the floor of the HEPN domain cleft
is lined with side chains of the invariant residues Arg415,
Asn416, and His422 from the R-X4-6-H motif. The
Asn416/His422 side chain pairs from the twoHEPN domains
bind a single Ni2+ ion in a tetragonal planar coordination
(Fig. 3A). As TtCsm6 and other HEPN domain ribonucleases
are divalent metal-independent enzymes (Fig. 1B; Anan-
tharaman et al. 2013), the observed Ni2+ ion binding in the
putative active site of TtCsm6 might be an artefact due to
crystallization in the presence of nickel(II) chloride. In
SmCsm6, the R-X4-6-H motif residues reside in an α helix,
whereas the TtCsm6 R-X4-6-H motif adopts an irregular
loop conformation, suggesting that the TtCsm6 active center
might be distorted as a result of Ni2+ binding (Fig. 3B).
Nevertheless, the disposition of the putative active site resi-
dues in TtCsm6 broadly resembles that observed in Ire1
and the related RNase L (Fig. 3B; Supplemental Fig. 6), sug-
gesting that Csm6 proteins use a similar mechanism of RNA
hydrolysis (Lee et al. 2008; Han et al. 2014; Huang et al.
2014). To confirm the catalytic function of the putative active
site residues in TtCsm6, we probed the ribonuclease activity
of TtCsm6 proteins in which the invariant R-X4-6-H motif
residues (Arg 415, Asn416, and His422) as well as a nearby
glutamate (Glu332) were substituted by alanine. As a control,
A
B
C
FIGURE 2. TtCsm6 is a helical homodimer containing N-terminal
CARF and C-terminal HEPN domains. (A) Overall architecture of the
TtCsm6 dimer shown in four orientations. (B) Comparison of the
three-dimensional structures of COG1517 family proteins: P. furiosus
Csx1 (PfCsx1, PDB ID 4EOG), S. mutans Csm6 (SmCsm6, PDB ID
4RGP), and S. solfataricus Csa3 (SsCsa3, PDB ID 2WTE). Structural su-
perpositions were performed using DALI (Hasegawa and Holm 2009).
(C) Surface representation of the TtCsm6 dimer colored according to
electrostatic surface potential. Themolecule is displayed in the same ori-
entations as in A.
Crystal structure of Csm6
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we tested TtCsm6 proteins in which the conserved CARF
domain residues Thr133 and Lys137 were mutated. All mu-
tant proteins were dimeric, as judged by size-exclusion chro-
matography (Supplemental Fig. 3). Individual substitutions
of the HEPN domain residues led to near-complete loss of ri-
bonuclease activity, whereas mutations in the CARF domain
had little effect (Fig. 3C; Supplemental Fig. 7). This indicates
that the ribonuclease activity of TtCsm6 is dependent on the
presence of an intact R-X4-6-H motif in the HEPN domain
while the CARF domain (D/N)-X-(S/T)-X3-(R/K) motif is
not directly involved in RNA hydrolysis. Additionally, to
test whether the HEPN domain is sufficient for ribonuclease
activity in TtCsm6, we generated a truncated TtCsm6 protein
lacking the N-terminal CARF domain (Δ1-190). This protein
FIGURE 3. The C-terminal HEPN domains of TtCsm6 form a composite endoribonuclease active site. (A) Overall view of the HEPN domain in-
terface in the TtCsm6 dimer. The inset shows a close-up view of the HEPN domain active site. Conserved active site residues are shown in stick format.
The Ni2+ ion present in the TtCsm6 crystal structure is shown as a green sphere. (B) Comparison of the HEPN ribonuclease active sites of yeast Ire1
(left), TtCsm6 (middle), and SmCsm6 (right). Active site residues are shown in stick format. The structures were aligned by least-squares superposition
of the active site Asn, Arg, and His residues and are shown in identical orientations. (C) Nuclease activity assays of active site mutants of TtCsm6. The
assays were performed using a 24-nt ssRNA substrate labeled with Cy5 at the 3′-end. Reactions were resolved on a 16% denaturing polyacrylamide gel
and analyzed on a fluorescence gel scanner. For conciseness, the panel depicts a cropped region of the denaturing gel; a full-size image of the gel is
shown in Supplemental Figure 7. (D) Ribonuclease activities of Csm6 orthologs. Recombinant T. thermophilus, S. epidermidis (SeCsm6), and P. hori-
koshii (PhCsm6) Csm6 proteins were incubated with a 24-nt Cy5-labeled ssRNA substrate at 37°C. Reactions were sampled at indicated time points
and analyzed as for Figure 1C. For conciseness, the panel depicts a cropped region of the denaturing gel; a full-size image of the gel is shown in
Supplemental Figure 8.
Niewoehner and Jinek
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was as active as full-length TtCsm6, showing that the CARF
domain is not required for enzymatic activation (Fig. 3C;
Supplemental Fig. 7). Collectively, these results confirm
that the ribonuclease activity of TtCsm6 is mediated by the
R-X4-6-H motif in the HEPN domain independently of the
CARF domain. In an analogy with the catalytic mechanisms
of Ire1 and RNase L (Lee et al. 2008; Han et al. 2014; Huang
et al. 2014), we propose that the dimerization of the HEPN
domains and the resulting juxtaposition of the R-X4-6-Hmo-
tifs lead to the formation of a composite symmetric active
center that binds the substrate RNA asymmetrically
(Supplemental Fig. 6B). The observation that TtCsm6 is a
metal-independent ribonuclease that generates products
containing a free 5′-hydroxyl group suggests that RNA hy-
drolysis involves a nucleophilic attack by the 2′-hydroxyl
group to yield a 2′,3′ cyclic phosphate, as shown for other
HEPN domain ribonucleases such as Ire1 and PrrC
(Amitsur et al. 1987; Gonzalez et al. 1999), and implies that
the HEPN active site residues in Csm6 likely serve the same
functions as their counterparts in Ire1 (Lee et al. 2008).
In the putative catalytic mechanism of Csm6, the active site
histidine His422 in TtCsm6 would thus function in general
acid–base catalysis, deprotonating the attacking 2′-hydroxyl
nucleophile and/or protonating the leaving 5′-hydroxyl
group, while Arg415 and Asn416 might mediate substrate
binding and transition state stabilization through ionic and
hydrogen bonding contacts.
Ribonuclease activity is conserved in Csm6
orthologs
Our structural and biochemical analysis of TtCsm6 suggests
that most Csm6 proteins are active ribonucleases. While the
biological function of TtCsm6 has not been studied in vivo,
deletion of the Csm6-encoding gene in S. epidermidis impairs
anti-plasmid immunity mediated by the type III-A CRISPR–
Cas system (Hatoum-Aslan et al. 2014). We therefore exam-
ined S. epidermidis Csm6 (SeCsm6) as well as Csm6 from
Pyrococcus horikoshii (PhCsm6), a hyperthermophilic eur-
yarchaeon, to probe whether these orthologs also possess ri-
bonuclease activities. Both proteins contain the canonical R-
X4-6-H HEPN domain motif and were therefore predicted to
be enzymatically active. We heterologously expressed and pu-
rified Csm6 proteins and assayed their activities alongside
TtCsm6. Both SeCsm6 and PhCsm6 proteins were able to
degrade a 24-nt ssRNA substrate at 37°C, confirming that
they are active ribonuclease enzymes (Fig. 3D; Supplemental
Fig. 8). The enzymes produced overlapping, but nonidentical
product patterns, suggesting that they may have slightly dif-
ferent substrate specificities. Together, these observations
suggest that endoribonuclease activity is a general feature of
Csm6 proteins. Furthermore, the conservation of the ribonu-
clease activity across different prokaryotic phyla strongly
hints at its functional significance in the context of type III-
A CRISPR-Cas systems.
Conclusions
Type III-A CRISPR–Cas systems have recently been shown to
target both ssRNA as well as dsDNA in a crRNA-guided man-
ner (Tamulaitis et al. 2014; Samai et al. 2015). The enzymatic
activities associated with these interference mechanisms re-
sidewithin theCsm interference complex. TheCsm3 subunits
of the Csm complex catalyze ssRNA degradation. In turn,
cleavage of a dsDNA target requires active transcription across
the target site and is dependent on the Csm1/Cas10 subunit.
The dual targeting specificity of the Csm complex is distinct
from those of type I and II CRISPR-Cas systems. In addition
to the Csm complex, a number of type III-ACRISPR–Cas sys-
tems include the HEPN domain-containing protein Csm6
that appears to be essential for their function (Hatoum-
Aslan et al. 2014). Based on the presence of a conserved
R-X4-6-H motif in their HEPN domains, Csm6 and Csx1
proteins were predicted to posses ribonuclease activities
(Anantharaman et al. 2013). Consistently, we show here that
Csm6 proteins from three divergent prokaryotes are active
RNases in vitro and that the R-X4-6-Hmotif is required for ri-
bonuclease activity in TtCsm6. The structure of TtCsm6 re-
veals that dimerization of the HEPN domains brings the R-
X4-6-Hmotifs of the two HEPN domain protomers into close
proximity, generating a composite ribonuclease active site that
resembles those found in KENdomain ribonucleases Ire1 and
RNase L (Lee et al. 2008; Han et al. 2014; Huang et al. 2014).
Together, our structural and biochemical studies demonstrate
that a subset of type III-ACRISPR–Cas systems contain an ad-
ditional ribonucleasemodule thatmay contribute to the inter-
ferencemechanisms of these systems and further expand their
capabilities against a broad spectrum of nucleic acid invaders.
Although Csm6 is required for efficient anti-plasmid inter-
ference mediated by the S. epidermidis type III-A CRISPR–
Cas system (Hatoum-Aslan et al. 2014), the functional im-
portance of the ribonuclease activity in Csm6 (and the related
Csx1 proteins) is presently unclear. It is possible that these
proteins degrade RNA transcripts of DNA invaders, thereby
augmenting the DNA- and RNA-targeting endonuclease ac-
tivities of the Csm complex. Notably, the RNA cleavage activ-
ity of the Csm complex itself is not essential for efficient
immunity against DNA plasmids in this context (Samai
et al. 2015). An intriguing alternative is that Csm6/Csx1 pro-
teins contribute to CRISPR immunity by targeting host (i.e.,
self) transcripts in order to induce dormancy or promote
programmed cell death of the host. In this way, these proteins
could provide a backupmechanism to restrict propagation of
the nucleic acid invader if the endonuclease activities of the
Csm effector complex are insufficient, as recently proposed
(Makarova et al. 2012). The presence of a highly conserved
pocket located at the dimer interface of the CARF domains
in Csm6 proteins additionally suggests that their catalytic
activity might be regulated in a ligand-dependent manner.
The crystal structure of TtCsm6 reveals that its dimeric
architecture would be highly suited for allosteric control,
Crystal structure of Csm6
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as conformational changes induced in the CARF domain
dimer by ligand binding could be transmitted by the 6H
domain to the ribonuclease active center at the HEPN
domain interface, thereby regulating its substrate binding af-
finity or catalytic activity. Ligand-dependent control of RNA
degradation by Csm6 could thus provide yet another layer of
host genome defense in type III CRISPR-Cas systems.
MATERIALS AND METHODS
Cloning, expression and purification
The sequences encoding TtCsm6 (TTHB152), PhCsm6 (PH_RS
00765), and SeCsm6 (SERP_RS12035) were PCR-amplified from
their respective genomic DNAs and inserted into a pET-based ex-
pression vector (2HRT, Addgene ID 29718) using ligation-indepen-
dent cloning. The resulting fusion protein constructs contained an
N-terminal hexahistidine tag followed by a tobacco etch virus
(TEV) protease cleavage site and the full-length protein sequence.
Point mutations were introduced using inverse PCR and verified
by DNA sequencing. All proteins were expressed in Escherichia coli
BL21 Rosetta 2 (DE3) cells. Cultures were grown at 37°C in the pres-
ence of 100 µg/mL ampicillin and 33 μg/mL chloramphenicol to an
optical density (OD600nm)of∼0.7. Expressionwas inducedby adding
IPTG to a final concentration of 200 µM and the cultures were grown
at18°C for16h.Harvestedcellswere lysedby sonication in lysis buffer
containing 20 mM HEPES pH 8.0, 500 mM KCl, 5 mM imidazole,
supplemented with protease inhibitors. The clarified lysate was ap-
plied to a 10-mL HIS-Select Nickel Affinity Gel (Sigma) column
and the column was subsequently washed with five column volumes
of the same buffer. Bound proteins were eluted with lysis buffer sup-
plemented with 250 mM imidazole. TEV protease was added to the
eluted fraction and the sample was dialyzed against 20 mM HEPES
7.5, 500 mM KCl at 4°C for 16 h. To remove the hexahistidine tag
and protein contaminants, the dialyzed proteins were re-applied to
a HIS-Select Nickel Affinity Gel column. The flow-through fraction
was collected, concentrated and further purified by size exclusion
chromatography using a Superdex 200 (26/600) column (GE
Healthcare Life Sciences) in 20 mM HEPES 7.5, 500 mM KCl.
Eluted Csm6 proteins were concentrated to 15–50 mg mL−1.
Crystallization and structure determination
Purified TtCsm6 protein was crystallized at 20°C using the hanging
drop vapor diffusion method by mixing equal volumes of protein
and reservoir solution. Initial crystals were obtained in 0.1 M
HEPES pH 7.5, 12% (w/v) PEG 3350, 5 mM CdCl2, 5 mM
CoCl2, 5 mM NiCl2, and 5 mM MgCl2 at protein concentrations
ranging from 6 to 25 mg mL−1. The optimal crystal growth condi-
tion was subsequently refined to 0.1 M HEPES pH 7.5, 14% (w/v)
PEG 3400 and 35 mM NiCl2 at protein concentrations ranging
from 5 to 10 mg mL−1. Iterative rounds of microseeding yielded
large single crystals that typically formed within few days and were
fully grown within 1–2 wk. For cryoprotection, crystals were trans-
ferred into 0.1 M HEPES pH 7.5, 12% (w/v) PEG 3400, 35 mM
NiCl2 and 35% (v/v) ethylene glycol and were flash-cooled in
liquid nitrogen. The crystals belonged to space group P21212 and
contained two TtCsm6 molecules in the asymmetric unit. X-ray
diffraction data were measured at beamline X06DA (PXIII) of the
Swiss Light Source (Paul Scherrer Institute, Villigen, Switzerland).
The data were indexed, integrated and scaled in XDS (Kabsch
2010). Native data were measured to a resolution of 2.30 Å. Experi-
mental phases were obtained from a single-wavelength anomalous
diffraction experiment measured at the Ni K-edge wavelength
(1.48502 Å). Anomalous scatterers were located using Phenix.hyss
(Zwart et al. 2008). Phasing and density modification were carried
out in Phenix.autosol (Terwilliger et al. 2009), resulting in a readily
interpretable electron density. The atomic model was built manually
in Coot and refined using Phenix.refine (Afonine et al. 2012). The fi-
nal model contains residues 1–167, 170–345, 349–367, and 371–464
in TtCsm6 molecule A, residues 1–15, 22–164, 171–346, 349–367,
and 371–464 in molecule B, 76 water molecules and 6 Ni2+ ions.
Nuclease assays
All synthetic RNA and DNA oligonucleotides were purchased from
Microsynth AG unless stated otherwise. Cleavage assays to deter-
mine substrate specificity were performed with 24 nt 3′-end Cy5 la-
beled synthetic RNA1 (ACUGCAACGCAAUAUACCAUAGCU)
and its nonlabeled complementary strand RNA2 (AGCUAUGGU
AUAUUGCGUUGCAGU). Corresponding DNA substrates were
3′-end Cy5 labeled DNA1 (ACTGCAACGCAATATACCATAGCT)
and its nonlabeled complementary strand DNA2 (AGCTATGGTA
TATTGCGTTGCAGT). DNA, RNA, and proteins were quantified
with a NanoDrop spectrophotometer using the calculated extinc-
tion coefficients at 260 nm for RNA1 (230 900 M−1 cm−1), RNA2
(223 700 M−1 cm−1), DNA1 (236 100 M−1 cm−1) and DNA2
(234 100 M−1 cm−1) and at 280 nm for TtCsm6 (105 660 M−1
cm−1 for homodimer), PhCsm6 (109 780 M−1 cm−1) and SeCsm6
(107 080 M−1 cm−1). To determine TtCsm6 substrate specificity
200 nM RNA1 were incubated with 400 nM TtCsm6 homodimer
in 20 mM HEPES pH 7.5 and 50 mM KCl and the reaction was in-
cubated for 1 h at 37°C. To prepare dsRNA and dsDNA substrates,
RNA1 and RNA2 as well as DNA1 and DNA2 oligonucleotides
were preincubated in a 1:2 stoichiometry, heated to 75°C and subse-
quently slow-cooled to room temperature. Cleavage reactions using
dsRNA, ssDNA, and dsDNAwere set up the same way as for ssRNA.
All reactions were quenched by addition of 0.5 volumes formamide
supplemented with 0.005% (w/v) bromophenol blue. Twenty mi-
croliters of the sample were loaded on a 15% denaturing (7 M
urea) polyacrylamide gel and resolved in 0.5× TBE at 55 W for 3 h.
The gels were visualized using a Typhoon FLA 9000 laser gel scanner
(GE Healthcare).
Nuclease activity assays to confirm endonuclease activity were
performed as follows. One hundred nanomolar RNA1 or RNA3
(identical oligonucleotides that carry a Cy5 label on the 3′-end
and 5′-end, respectively) were mixed with 200 nM TtCsm6 homo-
dimer in 20 mMHEPES pH 7.5 and 50 mM KCl (in a total reaction
volume of 150 µL) and the reactions were incubated at 37°C. Twenty
microliter samples were taken at indicated time points and reactions
were quenched by addition of 0.5 volumes formamide supplement-
ed with 0.005% (w/v) bromophenol blue. An RNase T1 control
digest was performed under the same conditions by substituting
TtCsm6 with 0.06 U of RNase T1 (Thermo Scientific). The samples
were resolved and visualized as above.
Ribonuclease activity assays to determine substrate preference of
TtCsm6 were conducted with synthetic homo-oligomeric RNAs
(A12, C12, and U12, respectively, obtained from Integrated DNA
Niewoehner and Jinek
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Technologies) labeled with Cy5 at their 3′ termini. Two-micromolar
substrates were incubated with 8 µM TtCsm6 at 37°C in 20 mM
HEPES pH 7.5 and 50 mM KCl in a total volume of 25 µL.
Three-microliter samples were taken at indicated time points and
the reactions were quenched by addition of 1 volume formamide
supplemented with 0.005% bromophenol blue. The samples were
resolved on a 20% denaturing (7 M urea) polyacrylamide gel and vi-
sualized as above.
In assays to determine the chemistry of RNA cleavage by TtCsm6,
4.5µMRNA1wasmixedwith20µMTtCsm6 in 2mMHEPESpH7.5
and 50mMKCl in a total reaction volume of 15 µL. The reaction was
incubated at 37°C for 15min, stopped by heat inactivation at 95°C for
15 min and centrifuged to remove precipitated denatured TtCsm6
protein. The supernatant was equally split into three 4-µL aliquots.
The first sample remained untreated. The second sample was mixed
with1mMATPand1×T4PolynucleotideKinasebuffer in a total vol-
ume of 10 µL (Thermo Fisher Scientific, final concentrations). The
third sample was treated the same way, but 0.5 U/µL T4 Polynucleo-
tideKinasewere added to the reaction (ThermoFisher Scientific). All
samples were then incubated at 37°C for 1 h and subsequently mixed
with 0.5 volumes of formamide supplemented with 0.005% bromo-
phenol blue. The alkaline hydrolysis ladder was generated as follows.
2.5 µMRNA1was incubated with 150mMNaHCO3, pH 9.6, at 95°C
for 1.5 h.Hydrolysis was stopped by addition of 150mMHCl and the
samplewasmixedwith0.5volumesof formamidesupplementedwith
0.005%bromophenolblue.All sampleswere resolvedona20%dena-
turing (7 M urea) polyacrylamide gel at 25 W for 4.5 h.
To perform TtCsm6 mutant cleavage assays, 1 µM RNA1 was in-
cubated with 2 µM TtCsm6 homodimer in 20 mM HEPES, pH 7.5,
and 50 mM KCl at 37°C (in a total reaction volume of 50 µL). Ten-
microliter samples were taken at indicated time points and reactions
were quenched by addition of 0.5 volumes formamide supplement-
ed with 0.005% (w/v) bromophenol blue. The samples were re-
solved on a 16% denaturing (7 M urea) polyacrylamide gel and
visualized as above.
Nuclease activity assays of Csm6 orthologs were performed by
mixing 250 nM RNA1 with 500 nM TtCsm6, 500 nM SeCsm6 or 5
µMPhCsm6 in 20mMHEPES, pH 7.5, and 50mMKCl in a total re-
action volume of 80 µL. Reactions were then incubated at 37°C. Ten-
microliter samples were taken at indicated time points and quenched
by adding 0.5 volumes of formamide supplemented with 0.005%
bromophenol blue. The samples were resolved on a 20% denaturing
(7 M urea) polyacrylamide gel and visualized as above.
DATA DEPOSITION
Atomic coordinates and structure factors of TtCsm6 have been
deposited in the Protein Data Bank under PDB code 5FSH.
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Supplemental material is available for this article.
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NOTE ADDED IN PROOF
While this manuscript was in revision, another study reported that
the Pyrococcus furiosusCsx1 protein is an adenosine-specific ribonu-
clease (Sheppard et al. 2016). These results are in broad agreement
with our structural and biochemical data on TtCsm6.
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